Det anbefales at patienter som får cladribine, får bestrålede cellulære blodbestanddele / - produkter for at forebygge transfusionsrelateret graft- versus- host sygdom (Ta- GVHD).
It is recommended that patients receiving cladribine should receive irradiated cellular blood components/ products to prevent transfusion-related graft-versus-host disease (Ta-GVHD).